Meike Ressing

Mainz, RP, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Can open source large language models be used for tumor documentation in Germany?-An evaluation on urological doctors' notes.

Can open source large language models be used for tumor documentation in Germany?-An evaluation on urological doctors' notes.

Journal: BioData mining
Published: January 21, 2025

Equivalent doses for anticancer agents used in pediatric oncology: A literature review and evaluation of a novel approach for conversion factors.

Equivalent doses for anticancer agents used in pediatric oncology: A literature review and evaluation of a novel approach for conversion factors.

Journal: Cancer reports (Hoboken, N.J.)
Published: October 19, 2022

Subsequent primary neoplasms after childhood cancer therapy - design and description of the German nested case-control study STATT-SCAR.

Subsequent primary neoplasms after childhood cancer therapy - design and description of the German nested case-control study STATT-SCAR.

Journal: Cancer causes & control : CCC
Published: August 22, 2022

Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study.

Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study.

Journal: International journal of cancer
Published: December 10, 2019

Response: Methods for second primary cancers evaluation have to be standardized.

Response: Methods for second primary cancers evaluation have to be standardized.

Journal: International journal of cancer
Published: October 09, 2017

Risk of second primary cancers in women diagnosed with endometrial cancer in German and Swedish cancer registries.

Risk of second primary cancers in women diagnosed with endometrial cancer in German and Swedish cancer registries.

Journal: International journal of cancer
Published: June 02, 2017

Strengthening health data on a rare and heterogeneous disease: sarcoma incidence and histological subtypes in Germany.

Strengthening health data on a rare and heterogeneous disease: sarcoma incidence and histological subtypes in Germany.

Journal: BMC public health
Published: April 12, 2017

Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21st century.

Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21st century.

Journal: Haematologica
Published: March 11, 2017

Survival for patients with rare haematologic malignancies: Changes in the early 21st century.

Survival for patients with rare haematologic malignancies: Changes in the early 21st century.

Journal: European journal of cancer (Oxford, England : 1990)
Published: February 09, 2017

Incidence of lip malignancies in Germany-data from nine population-based cancer registries.

Incidence of lip malignancies in Germany-data from nine population-based cancer registries.

Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
Published: February 03, 2017

Survival in patients with acute myeloblastic leukemia in Germany and the United States: Major differences in survival in young adults.

Survival in patients with acute myeloblastic leukemia in Germany and the United States: Major differences in survival in young adults.

Journal: International journal of cancer
Published: February 16, 2016

Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century.

Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century.

Journal: Journal of hematology & oncology
Published: February 01, 2016
Showing 1-12 of 15

Last Updated: 09/26/2026